首页> 外国专利> Dual SPECT/MRI contrast agent and a process for the preparation thereof

Dual SPECT/MRI contrast agent and a process for the preparation thereof

机译:SPECT / MRI双重造影剂及其制备方法

摘要

PURPOSE: A compound which contains radioactive isotopes and paramagnetic elements and is used as a single photon emission computed tomography/magnetic resonance imaging (SPECT/MRI) dual contrast agent is provided to be used as a contrast agent for MRI and a nuclear medical imaging instrument without toxicity to human body and to effectively diagnose cancer. CONSTITUTION: A compound is denoted by chemical formula 1. The compound has a structure of chemical formula 1a. A method for preparing the compound comprises the steps of: reacting a compound of chemical formula 3 with a compound of chemical formula 4; and labeling a meta site of tyrosine of Arg-Gly-Asp (RGD) with iodine. A gadolinium precursor is Gd (III)X_3. A SPECT contrast agent contains the compound. A SPECT/MRI dual contrast agent contains the compound. [Reference numerals] (AA,BB) Ligand
机译:目的:提供一种包含放射性同位素和顺磁性元素并用作单光子发射计算机断层扫描/磁共振成像(SPECT / MRI)双对比剂的化合物,以用作MRI和核医学成像设备的对比剂对人体无毒并能有效诊断癌症。组成:化合物用化学式1表示。该化合物具有化学式1a的结构。该化合物的制备方法包括以下步骤:使化学式3的化合物与化学式4的化合物反应;以及并用碘标记Arg-Gly-Asp(RGD)酪氨酸的位点。 precursor的前驱体是Gd(III)X_3。 SPECT造影剂包含该化合物。 SPECT / MRI双对比剂包含该化合物。 [参考数字](AA,BB)配体

著录项

  • 公开/公告号KR101336072B1

    专利类型

  • 公开/公告日2013-12-05

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20120001054

  • 申请日2012-01-04

  • 分类号C07F1;A61K49/04;A61K103/34;G01N23;

  • 国家 KR

  • 入库时间 2022-08-21 15:44:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号